Share
Oral Transmucosal Drugs Market: By Product Type (Tablets, Films, Liquid & Spray, and Others), By Route of Administration (Sublingual Mucosa, Buccal Mucosa, and Others), By Indication (Opioid Dependence, Nausea and Vomiting, Erectile Dysfunction, Neurological Disorders, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected to reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032
Oral transmucosal delivery means systemic administration of medication via the mucous membrane of the oral cavity. The transmucosal drug delivery system has various benefits making it profitable market. Transmucosal drug delivery permits drugs to bypass the body's natural defence mechanisms and are available in dosage forms like tablets, gels, thin films and they dissolve in the mouth. Oral transmucosal drugs can bypass hepatic first-pass metabolism and avoid degradation of drugs in the gastrointestinal tract.
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected to reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032 owing to increasing incidence of respiratory problems, autoimmune disorders, cancer, mucositis etc. The people getting affected by autoimmune disorders, respiratory problems, oral cancer, etc. are increasing leading to rise of the market across the world. This increases the requirement of oral transmucosal drugs to prevent gastrointestinal degradation and provide rapid onset of action. The number of patients with chronic diseases is rising across the world which increases the pre-surgical procedures which is expected to boost the global oral transmucosal drugs market.
Global Oral Transmucosal Drugs Market is classified based on the Product Type into Tablets, Films, Liquid & Spray, and Others. The Tablet segment is expected to witness growth over the forecast period. Oral transmucosal tablets dissolve in the mouth easily with little residue and they absorb quickly which is important in emergencies like heart attacks. The advantages of oral transmucosal tablets like predictable potency, ease of administration, and reduced side effects with other medications.
Global Oral Transmucosal Drugs Market is classified based on the Distribution Channel into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The retail pharmacy segment dominated the market in terms of revenue in 2021 owing to the factors like high availability of all the drug products related to the Oral Transmucosal delivery through the retail channels. The increasing inheritance of online pharmacy and ordering through mail are further expected to drive the growth Global Oral Transmucosal Drugs market.
Incidence of chronic diseases may boost the market growth
There is a rise in the prevalence rate of chronic diseases which may assist in the growth of the Global Oral Transmucosal Drugs Market. Due to the uneven eating habits and the consumption of food at irregular timings may lead to the occurrence of gastric issues, and the growth of gastrointestinal diseases might propel the market growth of the oral transmucosal drug market.
Rising R&D activities may drive the market growth
An increase in the prevalence of diseases is leading to the rise in research and development activities to invent new drugs with improved activities which is resulted in the growth of product launches pertaining to a disease and it is expected to boost the market growth over the forecast period. An increase in burden of diseases like Parkinson’s, migraine and the rising geriatric population with diseases may require the oral drugs may which may propel the growth of the oral transmucosal drugs market over the forecast period.
High Cost may restrain the market growth
The high cost of drug production may obstruct the market growth. There are few disadvantages of drug delivery by oral route like smaller surface area, low permeability when compared with sublingual membrane which may hamper the market growth. The regulatory changes in guidelines for combination products are changed regularly and which may restrain the market growth in the forecast period.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Global Oral Transmucosal Drugs Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Based on regional analysis, North America holds the major market share of oral transmucosal drugs market and is also expected to dominate the market in the forecast period owing to the high prevalence of diseases which require the administration of oral medications in people such with, Alzheimer's, PD, dental ailments, dysphagia and in the geriatric people. The rise in the number of dental visits in the country is also expected to drive the demand for oral transmucosal drugs.
The COVID-19 pandemic had a slight negative impact on the oral transmucosal drugs market due to the disruption in supply after the imposition of government lockdown, unavailability of workers and halting of the production activities. Oral transmucosal drugs market had importance during the pandemic as the drugs were important for the health of few patients in certain cases.
|
Report Attribute |
Details |
|
Market size value in 2021 |
USD 28.65 billion |
|
Revenue forecast in 2032 |
USD 58.2 billion |
|
Growth Rate |
CAGR of 6.7% from 2022 to 2032 |
|
Base year for estimation |
2021 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2032 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product Type, Route of Administration, Indication, Distribution Channel and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key companies profiled |
ZIM Laboratories Limited, Aquestive Therapeutics, Inc., IntelGenx Corp., C.L.Pharm Co., Ltd., Novartis AG, Seoul Pharmaceuticals, Pfizer Inc., Shilpa Therapeutics, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals, Inc. and Other Prominent Players |
Global Oral Transmucosal Drugs Market size was estimated at USD 28.65 billion in 2021 and is expected to reach USD 58.2 billion in 2032.
Transdermal drug delivery system transports medications through the skin for therapeutic purposes, a substitute to oral subcutaneous, intravascular, and transmucosal routes. The transmucosal drug delivery system has various benefits making it profitable market.
Tablets and Retail Pharmacy segment accounted for the largest Global Oral Transmucosal Drugs market share.
Key players: ZIM Laboratories Limited, Aquestive Therapeutics, Inc., IntelGenx Corp., C.L.Pharm Co., Ltd., Novartis AG, Seoul Pharmaceuticals, Pfizer Inc., Shilpa Therapeutics, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals, Inc. and Other Prominent Players are the key players in the Global Oral Transmucosal Drugs Market.
Incidence of chronic diseases and Rising R&D activities are the factors driving the Global Oral Transmucosal Drugs market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
